Effect of modified Taohongsiwu decoction on patients with chemotherapy- induced hand-foot syndrome

Journal of Traditional Chinese Medicine

Volumn 34, Issue 1, 2014, Pages 10-14

  Zhao, Changlin ^a,b   Chen, Jia ^a   Yu, Bin ^a   Wu, Xianlin ^a   Dai, Congqi ^a   Zhou, Chang ^a   Chen, Xiaoyin ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Hand foot syndrome; Modified Taohongsiwu decoction; Neoplasms; Quality of life

Indexed keywords

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; DEOXYCYTIDINE; DRUGS, CHINESE HERBAL; FEMALE; FLUOROURACIL; HAND-FOOT SYNDROME; HUMANS; MALE; MIDDLE AGED; NEOPLASMS;

EID: 84893848965     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Amy S C, Linda T V. Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapies. Support Cancer Therapy 2004; 1(4): 213-218.
2. Yuichiro A, Kojiro H, Kimie S, et al. Significant association between hand-foot syndrome and efficacy of capecitabine in patients with metastatic breast cancer. Biol. Pharm Bull 2012; 35(5): 717-724.
3. Thomas C W, Yang C, Peter R G, et al. Combination therapies with oxaliplatin and oral capecitabine or intravenous 5-FU show similar toxicity profiles in gastrointestinal carcinoma patients if hand-food syndrome prophylaxis is performed continuously. Oncol Lett 2012; 3(6): 1191-1194.
4. Vivian V G, Heidi F, Nancy F, et al. A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients. Cancer 2010; 116(20): 4735-4743.
5. Sherry L W, Rui Q, Smitha P, et al. Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced Hand-Foot Syndrome: North central cancer treatment group study N05C5. J Clin Oncol 2010; 28(35): 5182-5187.
6. Kang Y K, Lee S S, Yoon D H, et al. Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, doubleblind, placebo-controlled study. J Clin Oncol 2010; 28 (24): 3824-3829.
7. Vail D M, Chun R, Thamm D H, et al. Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model. Clin Cancer Res 1998; 4(6): 1567-1571.
8. Yoshimoto N, Yamashita T, Fujita T, et al. Impact of prophylactic pyridoxine on occurrence of hand-foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer. Breast Cancer 2010; 17(4): 298-302.
9. Blum J L, Jones S E, Buzdar A U, et al. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 1999; 17(2): 485-493.
10. Vincent S, Florence D, Christine C, et al. HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome. Oncologist 2011; 16(10): 1469-1478.
11. Hyunb S S, Woo Y L, Won S L, et al. Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy. Yonsei Med J 2009; 50(6): 796-802.
12. Katherina P F, Akmal S. Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment. Case Rep Oncol 2011; 4(1): 229-235.
13. Daigo Y, Chizuko Y, Satoru I, et al. Efficacy of vitamin E treatment for hand-foot syndrome in patients receiving capecitabine. Breast Care 2010; 5(6): 415-416.
14. Wang L, Jiao Z M, Li P. Traditional Chinese Medicine internal and external wash treatment for eight cases hand-foot syndrome caused by capecitabine. Zhong Yi Yan Jiu 2006; 19(4): 41-43.
15. Zhen X Y, Wu W G, Li P. The observation of Chinese herbal medicine for treatment of chemotherapy-related hand-foot syndrome. Guo Ji Yi Yao Dao Bao 2009; 15(8): 80-81.
16. Chang Z L, Wang D G. BYHWD prevention 45 cases hand-foot syndrome caused by capecitabinecapecitabine. Zhong Guo Zhong Yi Yao Xin Xi Za Zhi 2005; 12(6): 63-64.
17. Shao C D. Bazhen Tang treatment of capecitabine caused 30 cases of hand-foot syndrome. Xin Zhong Yi 2012; 44 (1): 79-80.
18. Liu C N. Chinese Well-known formulas and modified applications. Beijing: Science Press, 1999: 376-377.